Stephens Issues Pessimistic Forecast for Addus HomeCare (NASDAQ:ADUS) Stock Price

Addus HomeCare (NASDAQ:ADUS) had its price objective cut by Stephens from $140.00 to $135.00 in a research note issued on Wednesday,Benzinga reports. The firm presently has an “overweight” rating on the stock. Stephens’ target price indicates a potential upside of 29.78% from the company’s current price.

Several other brokerages also recently issued reports on ADUS. BMO Capital Markets assumed coverage on shares of Addus HomeCare in a research note on Thursday, November 13th. They issued a “market perform” rating and a $120.00 target price for the company. TD Cowen restated a “buy” rating on shares of Addus HomeCare in a research note on Wednesday, November 5th. Wall Street Zen upgraded Addus HomeCare from a “buy” rating to a “strong-buy” rating in a research note on Monday. Barclays decreased their target price on Addus HomeCare from $117.00 to $112.00 and set an “underweight” rating on the stock in a report on Tuesday. Finally, Royal Bank Of Canada reaffirmed an “outperform” rating and set a $139.00 price target on shares of Addus HomeCare in a report on Wednesday. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $134.33.

Addus HomeCare Price Performance

Shares of ADUS opened at $104.02 on Wednesday. The company has a current ratio of 1.80, a quick ratio of 1.66 and a debt-to-equity ratio of 0.11. The company’s fifty day simple moving average is $109.41 and its 200 day simple moving average is $113.01. Addus HomeCare has a 1-year low of $88.96 and a 1-year high of $124.43. The company has a market cap of $1.93 billion, a price-to-earnings ratio of 19.97, a PEG ratio of 1.49 and a beta of 0.91.

Insider Transactions at Addus HomeCare

In related news, EVP Darby Anderson sold 733 shares of the firm’s stock in a transaction dated Tuesday, February 24th. The shares were sold at an average price of $106.98, for a total transaction of $78,416.34. Following the transaction, the executive vice president directly owned 46,642 shares of the company’s stock, valued at approximately $4,989,761.16. This trade represents a 1.55% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP David W. Tucker sold 704 shares of Addus HomeCare stock in a transaction dated Tuesday, February 24th. The stock was sold at an average price of $107.35, for a total transaction of $75,574.40. Following the completion of the sale, the executive vice president owned 10,802 shares of the company’s stock, valued at $1,159,594.70. This trade represents a 6.12% decrease in their position. The SEC filing for this sale provides additional information. Over the last quarter, insiders sold 16,926 shares of company stock worth $1,804,969. 4.50% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in the business. Capital Research Global Investors boosted its holdings in shares of Addus HomeCare by 22.3% in the 4th quarter. Capital Research Global Investors now owns 1,469,752 shares of the company’s stock valued at $157,837,000 after purchasing an additional 268,192 shares in the last quarter. Tributary Capital Management LLC lifted its position in shares of Addus HomeCare by 114.1% during the 3rd quarter. Tributary Capital Management LLC now owns 398,122 shares of the company’s stock worth $46,974,000 after buying an additional 212,192 shares during the last quarter. Freestone Grove Partners LP boosted its stake in Addus HomeCare by 5,035.2% in the fourth quarter. Freestone Grove Partners LP now owns 137,932 shares of the company’s stock valued at $14,813,000 after buying an additional 135,246 shares in the last quarter. 8 Knots Management LLC bought a new position in Addus HomeCare in the third quarter valued at about $6,075,000. Finally, TimesSquare Capital Management LLC raised its stake in Addus HomeCare by 13.9% during the second quarter. TimesSquare Capital Management LLC now owns 394,047 shares of the company’s stock worth $45,390,000 after acquiring an additional 48,207 shares in the last quarter. 95.35% of the stock is owned by institutional investors.

Key Addus HomeCare News

Here are the key news stories impacting Addus HomeCare this week:

• Positive Sentiment: Stephens trimmed its price target from $140 to $135 but maintained an “overweight” rating, implying continued analyst confidence and ~30% upside vs. current levels. Analyst Price Target Cut
• Neutral Sentiment: Short-interest reporting appears inconsistent in recent automated feeds (some entries show 0 shares due to data issues), creating uncertainty around the true extent of short activity — watch official NYSE/NASDAQ or reliable data vendors for confirmation. MarketBeat ADUS Page
• Negative Sentiment: Multiple insider sales were disclosed for Feb. 24–25: CEO R. Dirk Allison and several EVPs sold shares (totaling hundreds to thousands of shares each). Concentrated insider selling often weighs on sentiment even when sales are for diversification or liquidity. SEC Filing (example)
• Negative Sentiment: An earlier Feb. 13 report showed materially higher short interest (≈1.15M shares, ~6.5% of float, ~4.6 days to cover), which can amplify downward pressure if sellers and short-covering activity accelerates. Confirmed short-interest updates should be watched closely. MarketBeat Short Interest

Addus HomeCare Company Profile

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.